1. Home
  2. EIG vs ARQT Comparison

EIG vs ARQT Comparison

Compare EIG & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • ARQT
  • Stock Information
  • Founded
  • EIG 2000
  • ARQT 2016
  • Country
  • EIG United States
  • ARQT United States
  • Employees
  • EIG N/A
  • ARQT N/A
  • Industry
  • EIG Property-Casualty Insurers
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • EIG Finance
  • ARQT Health Care
  • Exchange
  • EIG Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • EIG 1.1B
  • ARQT 1.7B
  • IPO Year
  • EIG 2007
  • ARQT 2020
  • Fundamental
  • Price
  • EIG $46.83
  • ARQT $14.12
  • Analyst Decision
  • EIG Strong Buy
  • ARQT Strong Buy
  • Analyst Count
  • EIG 1
  • ARQT 6
  • Target Price
  • EIG $58.00
  • ARQT $18.80
  • AVG Volume (30 Days)
  • EIG 174.3K
  • ARQT 2.0M
  • Earning Date
  • EIG 07-30-2025
  • ARQT 08-13-2025
  • Dividend Yield
  • EIG 2.71%
  • ARQT N/A
  • EPS Growth
  • EIG N/A
  • ARQT N/A
  • EPS
  • EIG 4.13
  • ARQT N/A
  • Revenue
  • EIG $860,200,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • EIG N/A
  • ARQT $61.15
  • Revenue Next Year
  • EIG $5.56
  • ARQT $37.98
  • P/E Ratio
  • EIG $11.45
  • ARQT N/A
  • Revenue Growth
  • EIG N/A
  • ARQT 100.03
  • 52 Week Low
  • EIG $42.05
  • ARQT $7.86
  • 52 Week High
  • EIG $54.44
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • EIG 45.73
  • ARQT 52.81
  • Support Level
  • EIG $46.43
  • ARQT $13.06
  • Resistance Level
  • EIG $47.91
  • ARQT $14.31
  • Average True Range (ATR)
  • EIG 0.80
  • ARQT 0.60
  • MACD
  • EIG 0.07
  • ARQT -0.00
  • Stochastic Oscillator
  • EIG 44.33
  • ARQT 61.96

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: